SLC7A11 as a biomarker and therapeutic target in HPV-positive head and neck Squamous Cell Carcinoma.


Journal

Biochemical and biophysical research communications
ISSN: 1090-2104
Titre abrégé: Biochem Biophys Res Commun
Pays: United States
ID NLM: 0372516

Informations de publication

Date de publication:
17 12 2020
Historique:
received: 10 09 2020
accepted: 29 09 2020
pubmed: 7 10 2020
medline: 27 3 2021
entrez: 6 10 2020
Statut: ppublish

Résumé

Ferroptosis, a regulated form of cell necrosis was previously reported to be induced upon pharmacological targeting of the cystine transporter SLC7A11 in Head and neck Squamous Cell Carcinoma (HNSCC). Whether tumors arising in a context of chronic infection with Human Papillomavirus (HPV) are sensitive to ferroptosis is unknown. Using RNAseq data (both whole-tumor and single-cell sequencing) we report that HPV positive (HPV

Identifiants

pubmed: 33019976
pii: S0006-291X(20)31896-9
doi: 10.1016/j.bbrc.2020.09.134
pii:
doi:

Substances chimiques

Amino Acid Transport System y+ 0
Biomarkers 0
E6 protein, Human papillomavirus type 16 0
Oncogene Proteins, Viral 0
Papillomavirus E7 Proteins 0
Piperazines 0
Repressor Proteins 0
SLC7A11 protein, human 0
erastin 0
Cystine 48TCX9A1VT
Phospholipid Hydroperoxide Glutathione Peroxidase EC 1.11.1.12
Glutathione GAN16C9B8O
Acetylcysteine WYQ7N0BPYC

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1083-1087

Informations de copyright

Copyright © 2020 Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Anais Hémon (A)

Equipe CHIMERE, EA7516, Université de Picardie Jules Verne, Amiens, France; Laboratoire de Biochimie, Centre de Biologie Humaine, CHU Amiens, France.

Christophe Louandre (C)

Equipe CHIMERE, EA7516, Université de Picardie Jules Verne, Amiens, France; Laboratoire de Biochimie, Centre de Biologie Humaine, CHU Amiens, France.

Claire Lailler (C)

Equipe CHIMERE, EA7516, Université de Picardie Jules Verne, Amiens, France; Laboratoire de Biochimie, Centre de Biologie Humaine, CHU Amiens, France.

Corinne Godin (C)

Equipe CHIMERE, EA7516, Université de Picardie Jules Verne, Amiens, France; Laboratoire de Biochimie, Centre de Biologie Humaine, CHU Amiens, France.

Maxime Bottelin (M)

Laboratoire de Biochimie, Centre de Biologie Humaine, CHU Amiens, France.

Virginie Morel (V)

Laboratoire de Virologie, Centre de Biologie Humaine, CHU Amiens, France.

Catherine François (C)

Laboratoire de Virologie, Centre de Biologie Humaine, CHU Amiens, France.

Antoine Galmiche (A)

Equipe CHIMERE, EA7516, Université de Picardie Jules Verne, Amiens, France; Laboratoire de Biochimie, Centre de Biologie Humaine, CHU Amiens, France. Electronic address: Galmiche.Antoine@chu-amiens.fr.

Zuzana Saidak (Z)

Equipe CHIMERE, EA7516, Université de Picardie Jules Verne, Amiens, France; Laboratoire de Biochimie, Centre de Biologie Humaine, CHU Amiens, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH